Corcept Therapeutics Inc (CORT)
28.09
+0.55
(+2.00%)
USD |
NASDAQ |
May 17, 16:00
28.09
0.00 (0.00%)
After-Hours: 20:00
Corcept Therapeutics Debt to Equity Ratio: 0.00 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | 0.00 |
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
Date | Value |
---|---|
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.0691 |
March 31, 2017 | 0.2039 |
December 31, 2016 | 0.3544 |
September 30, 2016 | 0.5993 |
June 30, 2016 | 0.7232 |
March 31, 2016 | 0.8093 |
December 31, 2015 | 0.809 |
September 30, 2015 | 1.002 |
June 30, 2015 | 1.044 |
March 31, 2015 | 1.008 |
December 31, 2014 | -2.782 |
September 30, 2014 | -6.576 |
June 30, 2014 | 2.142 |
March 31, 2014 | 0.7359 |
December 31, 2013 | 0.2733 |
September 30, 2013 | 0.1462 |
June 30, 2013 | 0.0904 |
March 31, 2013 | 0.0765 |
December 31, 2012 | 0.0429 |
September 30, 2012 | 0.4267 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2019
--
Maximum
Jun 2019
--
Average
--
Median
Jun 2019
Debt to Equity Ratio Benchmarks
Catalyst Pharmaceuticals Inc | 0.00 |
Regeneron Pharmaceuticals Inc | 0.0735 |
United Therapeutics Corp | 0.1124 |
Ligand Pharmaceuticals Inc | 0.00 |
NovaBay Pharmaceuticals Inc | 6.294 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 655.94M |
Total Liabilities (Quarterly) | 108.07M |
Shareholders Equity (Quarterly) | 547.86M |
Current Ratio | 5.179 |